Thus, Nrf2 utilizes different mechanisms to fulfill its anti-inflammatory roles, inhibiting cytokine expression in macrophages and promoting M-CSF expression in cancer cells, both of which inhibit macrophage activity autonomously or non-autonomously in a ROS-independent manner. The gene discussed is NFE2L2; the disease is cancer.